Oramed Pharmaceuticals Inc. Price Chart
Oramed Pharmaceuticals Inc. ORMP.TA Financial and Trading Overview
| Oramed Pharmaceuticals Inc. stock price | 822 ILA |
| Previous Close | 1406 ILA |
| Open | 1406 ILA |
| Bid | 1415 ILA x 0 |
| Ask | 1418 ILA x 0 |
| Day's Range | 1347 - 1417 ILA |
| 52 Week Range | 6.54 - 1417 ILA |
| Volume | 93.39K ILA |
| Avg. Volume | 115.36K ILA |
| Market Cap | 2.47M ILA |
| Beta (5Y Monthly) | 1.774647 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.999 ILA |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ORMP.TA Valuation Measures
| Enterprise Value | 409.04M ILA |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.9129108 |
| Price/Book (mrq) | 370.66455 |
| Enterprise Value/Revenue | 151.326 |
| Enterprise Value/EBITDA | -11.866 |
Trading Information
Oramed Pharmaceuticals Inc. Stock Price History
| Beta (5Y Monthly) | 1.774647 |
| 52-Week Change | 4.49% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1417 ILA |
| 52 Week Low | 6.54 ILA |
| 50-Day Moving Average | 11.57 ILA |
| 200-Day Moving Average | 18.8 ILA |
ORMP.TA Share Statistics
| Avg. Volume (3 month) | 115.36K ILA |
| Avg. Daily Volume (10-Days) | 61.22K ILA |
| Shares Outstanding | 17.38M |
| Float | 36.19M |
| Short Ratio | N/A |
| % Held by Insiders | 5.44% |
| % Held by Institutions | 12.63% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1278.35% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -13.0099% |
| Return on Equity (ttm) | -19.63% |
Income Statement
| Revenue (ttm) | 2.7M ILA |
| Revenue Per Share (ttm) | 0.07 ILA |
| Quarterly Revenue Growth (yoy) | 0% |
| Gross Profit (ttm) | 2.7M ILA |
| EBITDA | -34470000 ILA |
| Net Income Avi to Common (ttm) | -29531000 ILA |
| Diluted EPS (ttm) | -0.999 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 153.73M ILA |
| Total Cash Per Share (mrq) | 3.84 ILA |
| Total Debt (mrq) | 806K ILA |
| Total Debt/Equity (mrq) | 0.54 ILA |
| Current Ratio (mrq) | 31.206 |
| Book Value Per Share (mrq) | 3.777 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24342000 ILA |
| Levered Free Cash Flow (ttm) | -15313250 ILA |
Profile of Oramed Pharmaceuticals Inc.
| Country | Israel |
| State | NY |
| City | New York |
| Address | 1185 Avenue of the Americas |
| ZIP | 10036 |
| Phone | 844 967 2633 |
| Website | https://www.oramed.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's product portfolio includes ORMD-0801 Type 2, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes; ORMD-0801, Phase 2 oral insulin capsule for non-alcoholic steatohepatitis, a progressive liver diseases; and ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.
Q&A For Oramed Pharmaceuticals Inc. Stock
What is a current ORMP.TA stock price?
Oramed Pharmaceuticals Inc. ORMP.TA stock price today per share is 822 ILA.
How to purchase Oramed Pharmaceuticals Inc. stock?
You can buy ORMP.TA shares on the Tel Aviv exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oramed Pharmaceuticals Inc.?
The stock symbol or ticker of Oramed Pharmaceuticals Inc. is ORMP.TA.
How many shares does Oramed Pharmaceuticals Inc. have in circulation?
The max supply of Oramed Pharmaceuticals Inc. shares is 430.5K.
What is Oramed Pharmaceuticals Inc. Price to Earnings Ratio (PE Ratio)?
Oramed Pharmaceuticals Inc. PE Ratio is now.
What was Oramed Pharmaceuticals Inc. earnings per share over the trailing 12 months (TTM)?
Oramed Pharmaceuticals Inc. EPS is -0.999 ILA over the trailing 12 months.